No differences in the expression of markers related to either costimulatory or inhibitory functions, such as HLA-DR, CD86, and PD-L1, between healthy controls and COVID-19 patients within either neutrophil subset were detected (Fig. 2G and SI Appendix, Fig. S2). This evidence concerns the gene CD86 and COVID-19.